Celldex Therapeutics Inc. (CLDX)
NASDAQ: CLDX
· Real-Time Price · USD
24.86
-0.08 (-0.32%)
At close: Aug 15, 2025, 12:18 PM
-0.32% (1D)
| Bid | 21.16 |
| Market Cap | 1.65B |
| Revenue (ttm) | 7.56M |
| Net Income (ttm) | -178.85M |
| EPS (ttm) | -3.01 |
| PE Ratio (ttm) | -8.26 |
| Forward PE | -5.12 |
| Analyst | Buy |
| Ask | 28.74 |
| Volume | 471,507 |
| Avg. Volume (20D) | 1,167,666.5 |
| Open | 25.05 |
| Previous Close | 24.94 |
| Day's Range | 24.66 - 25.35 |
| 52-Week Range | 14.40 - 47.00 |
| Beta | 1.22 |
About CLDX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLDX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLDX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Celldex Therapeutics Inc. is scheduled to release its earnings on
Nov 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
10 months ago
-12.06%
Celldex Therapeutics shares are trading lower. The...
Unlock content with
Pro Subscription
